3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Muscular Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindsay, C; Musgaard, M; Russell, AJ; Sitsapesan, R | 1 |
| Bratina, A; Cheli, M; Dinoto, A; Manganotti, P; Sartori, A | 1 |
| Jaskowski, TD; La'ulu, SL; Mahler, M; Tebo, AE | 1 |
| Chalk, CH; Green, L; Maniatis, T; Pellerin, D; Singh, K | 1 |
| Beaufrére, AM; Boyer, O; Drouot, L; Lahaye, C; Soubrier, M; Tournadre, A | 1 |
| Quinn, C; Salameh, JS; Smith, T; Souayah, N | 1 |
| Konersman, CG; Mammen, AL; Nichols, L; Pfeifer, K; Shahnoor, N | 1 |
| Baker, SK; Tarnopolsky, MA | 1 |
2 review(s) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Muscular Diseases
| Article | Year |
|---|---|
Necrotizing myopathies: an update.
Topics: Acyl Coenzyme A; Antibodies; Humans; Muscle Fibers, Skeletal; Muscular Diseases; Necrosis | 2015 |
Statin-associated neuromyotoxicity.
Topics: Acyl Coenzyme A; Adverse Drug Reaction Reporting Systems; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Muscular Diseases; Peripheral Nervous System Diseases; Rhabdomyolysis; Terpenes; Ubiquinone | 2005 |
6 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Muscular Diseases
| Article | Year |
|---|---|
Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition.
Topics: Acyl Coenzyme A; Animals; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Muscle, Skeletal; Muscular Diseases; Rabbits; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sheep; Simvastatin | 2022 |
Diagnostic and treatment challenges of 3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy: the possible role of muscle ultrasound.
Topics: Acyl Coenzyme A; Autoantibodies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscles; Muscular Diseases | 2023 |
Detection of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme a reductase by ELISA in a reference laboratory setting.
Topics: Acyl Coenzyme A; Adult; Autoantibodies; Case-Control Studies; Creatine Kinase; Enzyme-Linked Immunosorbent Assay; Humans; Laboratories; Middle Aged; Muscular Diseases; Necrosis; Reference Standards | 2017 |
Mycophenolate Mofetil-Induced Status Epilepticus.
Topics: Acyl Coenzyme A; Antibiotics, Antineoplastic; Antibodies; Electroencephalography; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Muscular Diseases; Mycophenolic Acid; Status Epilepticus | 2018 |
Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
Topics: Acyl Coenzyme A; Aged; Autoantibodies; Autoimmune Diseases; Biopsy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulins, Intravenous; Male; Muscle, Skeletal; Muscular Diseases; Necrosis | 2014 |
An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy.
Topics: Acyl Coenzyme A; Atorvastatin; Autoantibodies; Autoimmune Diseases; Creatine Kinase; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Muscle, Skeletal; Muscular Diseases | 2015 |